
Last call! Attention to all our dedicated followers and partners. We’re moving all activity over to @invitae. Stay connected with the Inviate Ciitizen community by following us @Invitae.


Last call! Attention to all our dedicated followers and partners. We’re moving all activity over to @invitae. Stay connected with the Inviate Ciitizen community by following us @Invitae.

Thank you to all our dedicated followers and partners! We’re moving all activity over to @Invitae. We remain committed to enabling patients more control over their own health records for their personal care coordination needs. Follow us @Invitae

Have you followed @Invitae yet? Stay connected with the Invitae Ciitizen community by following us @Invitae.

We’re moving! Connect with the Invitae Ciitizen community by following us @Invitae

Have you heard? We’re moving over to @Invitae. Stay connected with the Invitae Ciitizen community by following us @Invitae.

Big news! We’re closing this account, but you can still follow us over at @Invitae. Thank you to all our dedicated followers and partners. We remain committed to enabling patients more control over their own health records for their personal care coordination needs.

👋 Friendly Reminder: #SYNGAP Seizure Tracker Study This is happening! Sign up for Ciitizen at Ciitizen.com/Syngap1 Log in at: app.Ciitizen.com @ciitizen @invitae #Studies #careaboutrare #rarediseaseresearch #syngap1

As a team built of #rare parents, we’re proud to sponsor this initiative. We're grateful to your organization & the #SYNGAP1 community who are proactively gathering and sharing invaluable insights and using tools like @Ciitizen/@Invitae to help us move innovation forward quickly.

“We were literally handed the raw data immediately”@PraxisMedicines on sourcing @cureSYNGAP1 data on @ciitizen and @Invitae! 💃🏻Also, still the handsomest little fella on that front page 😍 Thanks @JMGraglia, @McNamarVirginie, and team for making us a highly recruitable bunch!

News! @PraxisMedicines, who's developing an #ASO for #SYNGAP1 (#S10e58 @ Syngap.Fund/E58) is launching a study in partnership with #SRF & @ciitizen/@Invitae. Join us THIS Thurs to learn more. Register @ Syngap.Fund/Tracker. Ciitizen registry: Ciitizen.com/Syngap1

We're proud to partner with the Cholangiocarcinoma Foundation to help patients control their health data. Join this important research today: https://t.co/LGUQwi6XmG @curecc

Join Invitae's Ciitizen clinical study to improve medical research for 22q11.2 deletion syndrome. https://t.co/20W1NE9uul

We believe in patient-first research to improve future outcomes. Explore our current research opportunities and join us today to experience the free, secure benefits of Invitae’s Ciitizen. https://t.co/VKcDQcVQNw

We are excited to join @FamilieSCN2A at the #SCN2A Summer Seminar in-person this year, July 28-29th! Learn more about our SCN2A research study available now https://t.co/HePZH8WPSo #epilepsy #geneticepilepsy #genetictesting

Our PCDH19-Related Epilepsy Digital Natural History Study is now recruiting patients. Learn how to participate in this important research here: https://t.co/1lDl3UD47t

We're working with the Cholangiocarcinoma Foundation to improve the lives of #cholangiocarcinoma patients by accelerating research. Join us today. https://t.co/rrXbjbIj6l @curecc